Leukemia, Prolymphocytic, T-Cell - 15 Studies Found
Completed |
: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) : T-cell-prolymphocytic Leukemia : 2010-08-20 :
|
Withdrawn |
: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia :
: 2010-07-12 : Drug: Velcade IV Other Name: Bortezomib |
Completed |
: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) :
|
Completed |
: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia : Prolymphocytic Leukemia : 2006-01-16 :
|
Recruiting |
: Registry of the German CLL Study Group :
|
Recruiting |
: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant :
|
Active, not recruiting |
: Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma :
|
Active, not recruiting |
: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia :
|
Recruiting |
: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma :
|